Dr Reddy's Tests Financing Model For Sofosbuvir In India
This article was originally published in Scrip
Executive Summary
Out-of-the-box hepatitis C therapy financing initiatives in India, previously known to have improved access to interferon alfa 2b, are now being tested in the competitive sofosbuvir market in the country.